18F-Flortaucipir

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire De Toulouse, Kejal Kantarci

Conditions

Alzheimer’s DiseaseLewy Body Disease

Phase 2

Biomarkers of the locus coeruleus nucleus: links with early tau pathology, cognition and AD risk. LocusTau

Not yet recruitingCTIS2023-507668-38-00

Centre Hospitalier Universitaire De ToulouseAlzheimer’s Disease

Target: 100Updated: 2024-11-08

Phase 4

Longitudinal Imaging Biomarkers of Disease Progression in DLB

Enrolling by invitationNCT03582488

Kejal KantarciLewy Body Disease

Start: 2018-06-25End: 2027-09-01Target: 135Updated: 2026-03-19